Breaking News Instant updates and real-time market news.

CBAY

CymaBay

$5.65

-0.15 (-2.59%)

15:26
07/17/17
07/17
15:26
07/17/17
15:26

CymaBay price target raised to $18 from $13.50 at IFS Securities

IFS Securities analyst David Bouchey said 12 week top-line results from CymaBay's Phase 2 trial of seladelpar in Primary Biliary Cholangitis provides a strong basis to move on to Phase 3 and he has increased his projections for both seladelpar and arhalofenate. He raised his price target on CymaBay to $18 from $13.50 and keeps a Strong Buy rating on the stock.

  • 17

    Jul

CBAY CymaBay
$5.65

-0.15 (-2.59%)

07/17/17
HCWC
07/17/17
NO CHANGE
Target $12
HCWC
Buy
CymaBay price target raised to $12 from $7 at H.C. Wainwright
H.C. Wainwright analyst Ed Arce raised his price target for CymaBay (CBAY) to $12 saying the Phase 2 results of seladelpar in primary biliary cholangitis "are more robust" than Intercept Pharmaceutical's (ICPT) Ocaliva. The analyst notes that his new target reflects increased confidence in the approvability and market potential of seladelpar. He has a Buy rating on CymaBay.
07/12/17
OPCO
07/12/17
NO CHANGE
OPCO
CymaBay could see a 76% increment in value, says Oppenheimer
Oppenheimer analyst Jay Olson says CymaBay's shares could see a 76% increment in value if the July interim Phase 2 data for seladelpar supports removal of a partial clinical hold, enabling initiation of longer duration studies. The analyst estimates that the 5 and 10 mg dose in the Phase 2 trial will be efficacious and safe with a 67% probability of success. If positive, the stock price could move to $10 on the news, he adds.
06/22/17
OPCO
06/22/17
INITIATION
Target $8
OPCO
Outperform
CymaBay initiated with an Outperform at Oppenheimer
Oppenheimer analyst Jay Olson started CymaBay with an Outperform rating and $8 price target.
03/24/17
ROTH
03/24/17
NO CHANGE
Target $6
ROTH
Buy
CymaBay recent pull back represents 'attractive entry point,' says Roth Capital
Roth Capital analyst Sa'ar Yaniv notes that CymaBay expects that data from two arms of the ongoing, second Phase 2 study of seladelpar in primary biliary cholangitis will be released in Q3, and data from the third arm will be available by YE17. The analyst believes that shares continue to trade up in front of the data, and with recent pull back, the current price represents an "attractive entry point." He reiterates a Buy rating and $6 price target on the shares.

TODAY'S FREE FLY STORIES

GOOGL

Alphabet Class A

$969.03

-29.28 (-2.93%)

14:31
07/26/17
07/26
14:31
07/26/17
14:31
Recommendations
Alphabet Class A analyst commentary  »

Alphabet recent weakness…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XOP

SPDR Oil Exploration and Production Fund

$32.95

0.32 (0.98%)

14:30
07/26/17
07/26
14:30
07/26/17
14:30
Options
Sizable spread in SPDR Oil Exploration and Production ETF »

Sizable spread in SPDR…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:30
07/26/17
07/26
14:30
07/26/17
14:30
General news
FOMC takeaway: there was one subtle shift in the Fed's statement »

FOMC takeaway: there was…

YY

YY

$73.02

2.33 (3.30%)

14:25
07/26/17
07/26
14:25
07/26/17
14:25
Options
YY call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Aug

14:25
07/26/17
07/26
14:25
07/26/17
14:25
General news
FX Action: The dollar »

FX Action: The dollar…

14:20
07/26/17
07/26
14:20
07/26/17
14:20
General news
Treasury Action: yields whipsawed in the wake of the FOMC »

Treasury Action: yields…

ABX

Barrick Gold

$16.00

-0.04 (-0.25%)

14:20
07/26/17
07/26
14:20
07/26/17
14:20
Technical Analysis
Technical Earnings Preview: Barrick Gold range-bound before earnings »

Shares have been marking…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

AMZN

Amazon.com

$1,039.87

0.92 (0.09%)

, ULTA

Ulta Beauty

$256.61

4.53 (1.80%)

14:18
07/26/17
07/26
14:18
07/26/17
14:18
Hot Stocks
Piper says Amazon not near-term threat to Ulta Beauty »

Shares of Ulta Beauty…

AMZN

Amazon.com

$1,039.87

0.92 (0.09%)

ULTA

Ulta Beauty

$256.61

4.53 (1.80%)

EL

Estee Lauder

$98.85

0.1 (0.10%)

FB

Facebook

$165.28

-0.72 (-0.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 27

    Jul

  • 13

    Sep

WEC

WEC Energy

$62.56

0.38 (0.61%)

14:17
07/26/17
07/26
14:17
07/26/17
14:17
Earnings
WEC Energy sees Q3 EPS 63c-67c, consensus 72c »

Says guidance assumes…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

$NYE

NYSE Market Internals

14:16
07/26/17
07/26
14:16
07/26/17
14:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:15
07/26/17
07/26
14:15
07/26/17
14:15
General news
FOMC held rates steady and gave no firm date on the balance sheet unwind »

FOMC held rates steady…

SQM

SQM

$39.35

0.31 (0.79%)

14:10
07/26/17
07/26
14:10
07/26/17
14:10
Options
Call buyers opening a notable new position in Chemical and Mining of Chile »

Call buyers opening a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

14:05
07/26/17
07/26
14:05
07/26/17
14:05
General news
Federal Reserve says inflation declined and running below 2% »

The Federal Reserve said…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:05
07/26/17
07/26
14:05
07/26/17
14:05
General news
ECB's Nowotny agrees with Weidmann »

ECB's Nowotny agrees…

UMC

UMC

$2.45

-0.11 (-4.30%)

14:02
07/26/17
07/26
14:02
07/26/17
14:02
Downgrade
UMC rating change  »

UMC downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

14:02
07/26/17
07/26
14:02
07/26/17
14:02
General news
Fed says stance of monetary policy 'remains accommodative' »

The Federal Reserve said…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

14:01
07/26/17
07/26
14:01
07/26/17
14:01
General news
Fed sees balance sheet normalization 'relatively soon' »

The Federal Reserve said…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:01
07/26/17
07/26
14:01
07/26/17
14:01
General news
FOMC Meeting Announcement Federal Funds Rate data reported »

FOMC Meeting Announcement…

SPX

S&P 500

14:00
07/26/17
07/26
14:00
07/26/17
14:00
General news
Breaking General news story on S&P 500 »

Federal Reserve leaves…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RBS

RBS

$6.67

0.04 (0.60%)

13:58
07/26/17
07/26
13:58
07/26/17
13:58
Hot Stocks
RBS provides update on remaining State Aid obligation regarding Williams & Glyn »

Following the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UPS

UPS

$112.70

-0.52 (-0.46%)

, FDX

FedEx

$214.34

-0.03 (-0.01%)

13:50
07/26/17
07/26
13:50
07/26/17
13:50
Earnings
On The Fly: What to watch in UPS earnings report »

UPS (UPS) is scheduled to…

UPS

UPS

$112.70

-0.52 (-0.46%)

FDX

FedEx

$214.34

-0.03 (-0.01%)

BA

Boeing

$229.76

17.3 (8.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 27

    Jul

  • 07

    Aug

  • 21

    Aug

GG

Goldcorp

$13.56

0.14 (1.04%)

13:50
07/26/17
07/26
13:50
07/26/17
13:50
Options
Defensive option play in GoldCorp ahead of earnings »

Defensive option play in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

FCEL

FuelCell

$1.48

0.03 (2.07%)

13:50
07/26/17
07/26
13:50
07/26/17
13:50
Hot Stocks
Breaking Hot Stocks news story on FuelCell 

FuelCell trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

F

Ford

$11.06

-0.215 (-1.91%)

13:48
07/26/17
07/26
13:48
07/26/17
13:48
Hot Stocks
Ford drops after quarterly beat attributed to tax credits »

Shares of car giant Ford…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 01

    Aug

FB

Facebook

$165.28

-0.72 (-0.43%)

13:45
07/26/17
07/26
13:45
07/26/17
13:45
Periodicals
Facebook TV episodes ready for Mid-August, Bloomberg reports »

Facebook has asked…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 13

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.